BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 46 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $10,251,000 | +102.2% | 9,650,000 | +95.1% | 0.14% | +78.8% |
| Q1 2018 | $5,069,000 | -46.9% | 4,945,000 | -43.7% | 0.08% | -46.7% |
| Q4 2017 | $9,549,000 | -52.0% | 8,786,000 | -50.6% | 0.15% | -49.5% |
| Q3 2017 | $19,906,000 | -45.7% | 17,801,000 | -45.9% | 0.30% | -50.4% |
| Q2 2017 | $36,632,000 | -0.2% | 32,883,000 | +2.2% | 0.60% | +12.2% |
| Q1 2017 | $36,696,000 | -10.0% | 32,163,000 | -10.7% | 0.53% | -11.7% |
| Q4 2016 | $40,764,000 | -10.7% | 36,023,000 | -5.4% | 0.60% | +2.2% |
| Q3 2016 | $45,625,000 | -8.5% | 38,073,000 | -15.1% | 0.59% | -34.0% |
| Q2 2016 | $49,860,000 | +5.0% | 44,823,000 | +9.8% | 0.90% | +5.2% |
| Q1 2016 | $47,468,000 | +2968.4% | 40,810,000 | +3981.0% | 0.85% | +4638.9% |
| Q2 2015 | $1,547,000 | -96.9% | 1,000,000 | -97.0% | 0.02% | -96.5% |
| Q1 2015 | $49,182,000 | +15.1% | 33,083,000 | -8.3% | 0.52% | +13.6% |
| Q4 2014 | $42,718,000 | +15.4% | 36,083,000 | +4.6% | 0.46% | -25.4% |
| Q3 2014 | $37,002,000 | +30.9% | 34,510,000 | +26.6% | 0.61% | +24.3% |
| Q2 2014 | $28,273,000 | +5.7% | 27,250,000 | +12.4% | 0.49% | -2.4% |
| Q1 2014 | $26,747,000 | +35.1% | 24,250,000 | +31.1% | 0.50% | +38.7% |
| Q4 2013 | $19,797,000 | – | 18,500,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|